BackKezar Life Sciences Overview

Kezar Life Sciences Current Assets

Latest current assets for KZR: $68M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$67.56M
↓ 43.85% YoYΔ $-52.76M vs prior year quarter

Peer trimmed avg / median

Loading

Kezar Life Sciences Current Assets History

Loading

Kezar Life Sciences vs. peers: Current Assets Comparison

Loading

Kezar Life Sciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kezar Life Sciences (KZR) FAQ

As of the most recent data (March 2026), KZR shows a current assets of $68M. That compares with $120M in the prior-year period — down 43.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KZR's current assets is now $68M (was $120M) — a 43.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Kezar Life Sciences is outperforming or lagging.

Tracking KZR's current assets over time shows whether Kezar Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $68M That compares with $120M in the prior-year period — down 43.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Kezar Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $68M) with ownership activity and broader fundamentals.

Kezar Life Sciences's current assets is $68M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.